India's FIPB clears more FDI deals

October 1, 2013 | Tuesday | News | By BioSpectrum Bureau

India's Foreign Investment Promotion Board (FIPB) cleared 15 Foreign Direct Investment (FDI) proposals worth $322.58 million

India's Foreign Investment Promotion Board (FIPB) cleared 15 Foreign Direct Investment (FDI) proposals worth $322.58 million

New Delhi: India's finance ministry has released a statement announcing that the country's Foreign Investment Promotion Board (FIPB) cleared 15 Foreign Direct Investment (FDI) proposals worth $322.58 million.

These proposals, the statement said had been considered on August 27 by the board. The board recommended IDFC Trustee Company's proposal to set up an alternate investment fund for the consideration of the CCEA. The expected foreign inflow is $887.09 million.

Proposals by Jubilant Pharma Pte, Singapore, Lotus Surgical Specialities, Symbiotec Pharmalab and Advanced Enzyme Technologies were cleared by the board.

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls